Ovid Therapeutics (OVID) Payables (2016 - 2026)
Ovid Therapeutics (OVID) recorded Payables of $4.07 million in Q2 2026, up 3.1% from $3.95 million a year earlier but down 54.1% from the prior quarter.
Powered by 
Analysis
Ovid Therapeutics (OVID) Payables (2016 - 2026) Analysis & Trends
At the end of FY2025, Ovid Therapeutics reported Payables of $1.96 million, down 38.7% from FY2024.
- Annual Payables has a five-year compound annual growth rate of -18.5% (FY2020 to FY2025).
- Across earlier years, Payables came in at $3.19 million in FY2024 (-13.8%), $3.7 million in FY2023 (+89.6%), $1.95 million in FY2022 (-72.6%) and $7.13 million in FY2021 (+30.9%).
- Quarterly Payables has ranged from $1.03 million in Q3 2022 to $8.88 million in Q1 2026 over the past five years.
- On a year-over-year basis, Payables rose in three of the last eight quarters, with growth averaging 41.2%.
- Peak year-over-year performance for Payables in the last five years was growth of 407.6% in Q2 2022, against a decline of 72.6% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $8.88 million (Q1 2026), $1.96 million (Q4 2025) and $1.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Ovid Therapeutics | 454.50 Mn | 86.52 Mn | - | 4.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.07 Mn |
| Mar 31, 2026 | 8.88 Mn |
| Dec 31, 2025 | 1.96 Mn |
| Sep 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 3.95 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Dec 31, 2024 | 3.19 Mn |
| Sep 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 4.72 Mn |
| Mar 31, 2024 | 3.60 Mn |
| Dec 31, 2023 | 3.70 Mn |
| Sep 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | 3.76 Mn |
| Mar 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 1.95 Mn |
| Sep 30, 2022 | 1.03 Mn |
| Jun 30, 2022 | 4.62 Mn |
| Mar 31, 2022 | 2.26 Mn |
| Dec 31, 2021 | 7.13 Mn |
| Sep 30, 2021 | 3.14 Mn |
API Access
Ovid Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();